Integrating Radioligand Therapy into mCRPC Clinical Practice: From Taiwan and Japan Experience

Introduce the treatment options and trends for mCRPC (metastatic castration-resistant prostate cancer) medications and share the Xofigo real-world data from Taiwan and Japan.